SlideShare a Scribd company logo
1 of 36
Download to read offline
Innate immunity and HIV infection



         Jacek Skowronski, PhD
     Case Western Reserve University

           November 5, 2012
vif            vpu
      HIV-1                       gag
                                          pol
                                                              env
                                                  vpr                     nef
                                                  vif
                                   gag
      HIV-2/SIVsm                           pol
                                                                    env
                                                        vpx, vpr            nef




1. Background: HIV accessory virulence factors Vpx and Vpr

2. Vpx and Vpr function through CRL4DCAF1 E3 ubiquitin ligase

3. Identification of cellular protein, SAMHD1, Vpx targets for degradation via
   CRL4DCAF1

4. SAMHD1 inhibits HIV infection in quiescent cells

5. Ongoing SAMHD1 studies
The innate immune system protects from viral infection.




                                Short J A Bioscience Horizons 2009;2:212-224
The innate immune system matrix.




                                                     Block IFN
                                                     synthesis
                                                             IFN – R
                                                             decoys
                                                             Block IFN
                                                             signaling




                                                   Block ISG
                                                   function




                    Short J A Bioscience Horizons 2009;2:212-224
The innate immune system matrix.




                                TRIM5
                                TRIM28/KAP1
                                APOBEC3G/F
                                Tetherin/BST2
                                Schlafen 11
                                XYZ??


                    Short J A Bioscience Horizons 2009;2:212-224
The innate immune system matrix.




                                TRIM5                   HIV:
                                TRIM28/KAP1             Evades
                                APOBEC3G/F              Counteracts
                                Tetherin/BST2           Ignores
                                Schlafen 11
                                X ??


                    Short J A Bioscience Horizons 2009;2:212-224
HIV accessory proteins program degradation of restriction factors



                                                    vif            vpu
          HIV-1                         gag
                                                 pol
                                                                       env
                                                          vpr                          nef
                                                          vif
                                         gag
          HIV-2/SIVsm                               pol
                                                                             env
                                                                vpx, vpr                 nef




                  Target:           Accessory protein            E3 Ubiqitin ligase:

                  APOBEC3G/F        Vif                          CRL5
                  Tetherin          Vpu                          SCF--TrCP
                  XYZ??             Vpr, Vpx                     CRL4-DCAF1

                               –> degradation by proteasome
HIV accessory proteins program degradation of restriction factors




               Function and regulation of E3 Ubiquitin ligases

                          Roc1     target
            Nedd8        (CyP F)
                                                           Ub

                                             E2             E1    26 S
                                                                  proteasome
                                             Ub
                    E3             E3
                                             E2             E1

                                        Ub           UbUbUbUbUb
            Nedd8         CSN
                                   target         target
HIV accessory proteins program degradation of restriction factors




          HIV-1                         gag
                                                 pol
                                                                       env
                                                          vpr

                                         gag
          HIV-2/SIVsm                               pol
                                                                             env
                                                                vpx, vpr




                  Target:           Accessory protein            E3 Ubiqitin ligase:

                  APOBEC3G/F        Vif                          CRL5
                  Tetherin          Vpu                          SCF--TrCP
                  XYZ??             Vpr, Vpx                     CRL4-DCAF1

                               –> degradation by proteasome
Vpr and Vpx functions:

                                                 DNA damage                              Transduction
                                                                Transcription
                                                checkpoint (G2)                      of Macrophages/DC
                                Vpr (HIV-1)           +++                ++                    +


                                Vpr (SIVmac)           +++               ?                     –


                                Vpx (SIVmac)           –                 ?                 +++++

HIV-1 Vpr        MEQAP-EDQGPQ--REPYNEWTLELLEELKSEAVRHFPRIWLHNLGRHIYETYGDTWAGVEAIIR-----ILQQLPFIHFRIGCRHSRIGV-TRQRRARNG--ASRS*
SIVmac Vpr       MEERPPENEGPQ--REPWDEWVVEVLEELKEEALKHFDPRLLTALGNHIYNRHGDTLEGAGELIR-----ILQRALFMHFRGGCIHSRIGQ-PGGGNPLSAIPPSRSML*
SIVmac Vpx   MSDPRERIPPGNSGEETIGEAF-EWLNRTVEEINREAVNHLPRELIFQVWQRSWEYWHDEQGMSPSYVKYRYLCLIQKALFMHCKKGCRCLGEGHGAGGWRPGPPPPPPPGLA*




                                                                                    

       X-RAY                                                                 NMR
                                  

                           

                      
Vpx overcomes inhibition of HIV infection of MDM and MDDC




                                        Negre et al. (2000) Gene Ther 7:1613
                                        Goujon et al. (2007) Retrovirology 4:2
                                        Kaushik et al. (2009) Cell Host Microbe 6:68
                                        Pertel et al. (2011) Retrovirology 8:49
Vpx and Vpr target CRL4 DCAF1 E3 Ubiquitin ligase


                                                                    CRL4 E3
     Vpx/Vpr
                                                                   architecture
     Complex
   Identification
                                                                    DDB1




                                       Catalytic core

                                                        Cullin 4




                                                                                    specificity
                                                                                    Substrate
                                                                    CSN
                                                                          DCAF1
    Vpx, Vpr
 Epitope tagging


    Expression                                            Vpx/Vpr-bound
                                                          protein complex

Affinity purification                  DDA1
                                                              DDB1




                                                                          DCAF1


                                                                                  specificity
                                                                                  Substrate
   LC-MS/MS
                                                        Vpr/
(shotgun/MudPIT)
                                                        Vpx
Architecture of Cullin 4-based E3 ubiquitin ligase complexes


                                                                             “WD40” substrate receptors:
        Catalytic core              DDB1                                       DCAF1-19

                         Cullin 4




                                                    specificity
                                                    Substrate
                                                                               DDB2
                                    CSN
                                                                               CSA
                                           “WD40”
                                                                               Cdt2
                                                                               VprBP/DCAF1




                                                                                   10%       sucrose       40%
Vpr/Vpx bound complex:
                                                                  Blot:            66      232   660 kD

 DDA1                                                                DCAF1
        DDB1                                           IP:           DDB1
                            DCAF1




                                                       VprBP
                                      specificity
                                      Substrate




                                                                     DDA1          VprBP
      Vpr/                                                           DCAF1
      Vpx
                                                         IP:         DDB1
                                                         Vpr         DDA1
                                                                     Vpr
Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3




                                                             E3
                                                           active
                                                        or inactive ?
DDB1
                                              Vpr/Vpx
       DCAF1
                               DDB1                                DDB1
                    Cullin 4




                                                        Cullin 4
                                      DCAF1                               DCAF1
         Cullin 4
Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3

              Roc1          target                   Assembly of Cul4DCAF1 E3
Nedd8        (CyP F)
                                                     + / - Vpr in HEK 293T cells
                                         E2
                                         Ub
        E3             E3                         Purification via DCAF1 subunit


                                         E2
               CSN                            Incubation with E2 & Ubiquitin

Nedd8
                              Ub

                            target            SDS PAGE for poly-Ub Cul4




26 S
                                                          DDB1                      DDB1
proteasome
                                               Cullin 4




                                                                         Cullin 4
                                    Ub                                                     DCAF1
                                                                 DCAF1
                                  Ub
                                Ub
                                                                                    Vpr
                              Ub                                  tag                      tag
                            target
                                                            “WD40”: DCAF1
Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3
                                    Vpr:          –    –    +     –               +
                  target            E2:           –    –    –     +               +
Nedd8


                               E2
                               Ub
        E3   E3
                                                                                        Cul4(Ub)n
                               E2
                                                                                       Cul4
Nedd8
                    Ub

                  target
                                                  1    2    3      4              5


26 S
                                                  DDB1                            DDB1
                                       Cullin 4
proteasome




                                                                       Cullin 4
                          Ub                                                                DCAF1
                                                           DCAF1
                        Ub
                      Ub
                                                                                      Vpr
                    Ub                                      tag                             tag
                  target
                                                      “WD40”: DCAF1
Vpr (&Vpx) elevates neddylation of DCAF1 associated Cul4
                                           IP:              f-Vpr             f-DCAF1                       f-DDB2
Nedd8                               f–Vpr:       +          +   +   –     –    –   –    –            –      –   –   –      –
                                    f–VprBP:     –          –   –   –     +    +   +    –            –      –   –   –      –
                                    f–DDB2:      –          –   –   –     –    –   –    –            +      +   +   +      –
                                    m-Cul4A:     –          +   +   +     –    +   +    +            –      +   +   +      +
                                    Vpr:         +          +   +   +     –    –   +    +            –      +   –   +      +
        E3   E3                     VprBP:       –          –   +   +     +    +   +    –            –      –   +   +      +




                               Extract
                                         Cul4                                                                                  *

Nedd8                                    Cul4                                               *
                               IP



                                         Nedd8
                                                                                            *

                             DDB1                           DDB1                                           DDB1




                                                                                                Cullin 4
                  Cullin 4




                                                 Cullin 4



                                         DCAF1
                                         VprBP                      DCAF1
                                                                    VprBP                                           DDB2
                                                                                                                     tag
                                                             Vpr
                                          tag                       tag


                                         “WD40”: VprBP
                                                 DCAF1                                 “WD40”: DDB2
Vpx/Vpr usurp CRL4DCAF1 to destroy novel restriction factors




                    Roc1
      Nedd8        (CyP F)


                    Vpr
              E3    Vpx      E3



      Nedd8         CSN
Vpx/Vpr usurp CRL4DCAF1 to destroy novel restriction factors




                                  Novel Restriction
                                  Factors for HIV/SIV
                    Roc1
      Nedd8        (CyP F)
                                                          Ub
                                                           E1            26 S
                    Vpx                  E2                              proteasome
                                        Ub
              E3    Vpr      E3
                                         E2                E1

                                   Ub            UbUbUbUbUb
      Nedd8         CSN
                                                        Le Rouzic et al. 2007 Cell Cycle 6:182-8
                                                        Schröfelbauer et al. 2007. PNAS 104::4130-5
                                                        Hrecka et al. 2007. PNAS 104:11778-83
                                                        De Hart et al. 2007 Virol J. 4:57
                                                        Wen et al. 2007 JBC 282:27046-57
                                                        Srivastava et al. 2009 PLoS Path. 4:e1000059
                                                        …
Searches for substrates recruited by Vpr/Vpx to CRL4DCAF1 E3




      1. Substrate trapping by Vpx/Vpr on CRL4DCAF1

      1. Global analysis of DC proteomes following SIV VLP(Vpx)
         infection
Substrate trapping on CRL4DCAF1 by Vpx/Vpr

Vpx         CRL4DCAF1–Vpx               CRL4DCAF1             CRL4DCAF1–Vpr       Vpr (H/S)

              DDA1                      DDA1                   DDA1


                          DDB1                      DDB1                   DDB1




                                         Cullin 4




                                                                Cullin 4
               Cullin 4


                          HA-                                               HA-
HA- FLAG-                                                                         HA- FLAG-
            FLAG-                     FLAG-                  FLAG-
                                                       HA-




                                transient co-expression


                     affinity purification of E3 complexes


                                       MudPIT
Cellular proteins loaded by Vpx onto CRL4DCAF1 by Vpx
Putative Vpx substrates trapped on CRL4DCAF1
MudPIT analysis of MDDC proteomes following
           SIV VLP(Vpx) infection

           CD14+ monocytes

                        GMCSF, IL-4

                MDDC

                        (+/- type I IFN)

                        SIV VLP +/- Vpx

               Extracts
               (cyt or nuc)




                MudPIT
Analysis of MDDC proteomes identifies SAMHD1 as Vpx
  target

MDDC          SIV VLP   IFN   SAMHD1   A3C   A3A    spectra    proteins
extract
Cytoplasmic      –       –      35      0     0    14085       1048

Nuclear          –       –      17      10    0    18077       1992

Cytoplasmic     Vpx      –      0       2     0    25878       1536

Nuclear         Vpx      –      0       5     0    15803       1714

Cytoplasmic      –      IFN     65      1     7    28047       1912

Nuclear          –      IFN     39      6     2    16962       2018

Cytoplasmic     Vpx     IFN     0       0    13    33280       2158

Nuclear         Vpx     IFN     0       10    2    25619       2498
Analysis of MDDC proteomes also identifies SAMHD1 as Vpx target




MDDC          SIV VLP   IFN   SAMHD1   A3C   A3A    spectra    proteins
extract
Cytoplasmic      –       –      35      0     0    14085       1048

Nuclear          –       –      17      10    0    18077       1992

Cytoplasmic     Vpx      –      0       2     0    25878       1536

Nuclear         Vpx      –      0       5     0    15803       1714

Cytoplasmic      –      IFN     65      1     7    28047       1912

Nuclear          –      IFN     39      6     2    16962       2018

Cytoplasmic     Vpx     IFN     0       0    13    33280       2158

Nuclear         Vpx     IFN     0       10    2    25619       2498
SAMHD1 inhibits HIV infection
                       and
is targeted by Vpx for degradation via CRL4DCAF1
Vpx-recruits SAMHD1 to CRL4DCAF1 complex
Vpx programs SAMHD1 degradation via CRL4DCAF1 in MDM
SAMHD1 inhibits HIV/SIV infection in macrophages




                                        MDM

                               D0    Monocytes +GMCSF
                               D3    VLPVpx
                               D6    siRNA
                               D9    infect/western
                               D10   Q-PCR
                               D12   FACS
SAMHD1 inhibits HIV/SIV infection in macrophages




                                       Protocol

                               D0    Monocytes +GMCSF
                               D3    VLPVpx
                               D6    siRNA
                               D9    infect/western
                               D10   Q-PCR
                               D12   FACS
SAMHD1 inhibits HIV/SIV infection in macrophages
Conclusions



1. SAMHD1 inhibits HIV/SIV infection in macrophages, and other monocyte
   derived cell lineages.

2. SAMHD1 inhibits infection by interfering with viral cDNA synthesis.

3. SAMHD1 restriction is counteracted by Vpx.

4. Vpx targets SAMHD1 for proteasomal degradation via CRL4DCAF1 E3 Ub
   ligase.




                                         Hrecka et al. 2011 Nature 474:658-61
                                         Laguette et al. 2011 Nature 474:654-7
                                         Berger et al. 2011 PLoS Pathogens 7:e1002425
SAMHD1: short story
SAMHD1                                                       SAMHD1 (626aa)
1. dGTP-dependent dNTPase
                                                               HD
2. Located in nucleus                               SAM
3. Expressed in most leukocytes (HSC, B,
                                                     allo          COG1078
   T, monocytes)                                     site

Anti-inflamatory
5. Loss of function (lof) SAMHD1 mutations                  dNTP     dN + PPP
   are associated with autoimmune
   inflammatory condition (AGS) resembling
   congenital viral infection.
6. AGS is also caused by lof mutations in
                                                ?
   nucleases TREX1 and RNAseH2.                                                      RT
7. SAMHD1, TREX1 and RNAseH2 prevent
   accumulation of cellular immuno-
   stimulatory DNA that activates type I IFN     endo-immuno-
                                                 stimulatory DNA             Viral cDNA
   response via cytoplasmic sensors.

Anti-viral                                                            IFN
7. Inhibits HIV/SIV cDNA synthesis by
   suppressing dNTP pools below the
   threshold required for RT to function       anti-inflamatory                 anti-HIV
   efficiently.                                      (AGS)
Outstanding questions:

Anti-viral:
•   SAMHD1 functions important for anti–viral function, besides catalytic activity.
     • is SAMHD1 proximity to RTC important
     • RTC recognition
     • is restriction regulated
     • how does Vpx counteract SAMHD1
•   SAMHD1 and innate response to HIV
     • does SAMHD1 prevent HIV triggering of innate sensors and type I IFN response
       in monocytes/DC/macrophages?
     • Identity of cytoplasmic sensors that mediate this response

Anti-inflamatory
•   what is the nature of immunostimulatory DNA whose accumulation SAMHD1 prevents?
•   cytoplasmic sensors that mediate type I interferon response
Collaborators:

Case:                Case:
                     David McDonald
Caili Hao            Marcin Golczak
                     Michael Lederman
Kasia Hrecka
Sarabpreet Kaur      Stowers Institute:
Sheeba Rasheedi      Mike Washburn
Chuanping Wang       Laurence Florens
Junpeng Yan          Selene K . Swanson

                     U. Pitt & PCHPI:
CSHL                 Angela Gronenborn
                     Joanne Yeh
                     Jinwoo Ahn
Magda Gierszewska*
Smita Srivastava*    Skirball Inst. & HHMI:
                     Dan Littman
                     Nicolas Manel

More Related Content

What's hot

THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...
THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...
THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...Dr.Dinesh Amarasekara
 
Means of Treating Botulinum Neurotoxin Persistence
Means of Treating Botulinum Neurotoxin PersistenceMeans of Treating Botulinum Neurotoxin Persistence
Means of Treating Botulinum Neurotoxin Persistencegoyler
 
applications of polymerase chain reaction
applications of polymerase chain reactionapplications of polymerase chain reaction
applications of polymerase chain reactionVivekAbhyankar1
 
Viruses fight back against rn ai technology
Viruses fight back against rn ai technologyViruses fight back against rn ai technology
Viruses fight back against rn ai technologySenthil Natesan
 
Izortze diatrain
Izortze diatrainIzortze diatrain
Izortze diatraindiatrain
 
HIV Vaccines
HIV VaccinesHIV Vaccines
HIV VaccinesPamoja
 
Humanretroviruses 120401050128-phpapp01
Humanretroviruses 120401050128-phpapp01Humanretroviruses 120401050128-phpapp01
Humanretroviruses 120401050128-phpapp01Sarah Abhinay
 
Gene therapy 2010
Gene therapy 2010Gene therapy 2010
Gene therapy 2010tcha163
 
12 merialberlinhansnauwynck
12 merialberlinhansnauwynck12 merialberlinhansnauwynck
12 merialberlinhansnauwynckMerial EMEA
 
PhD; Qualification exam (mesele)2
PhD; Qualification exam (mesele)2PhD; Qualification exam (mesele)2
PhD; Qualification exam (mesele)2Mesele Tilahun
 
Hepatitis b virus for PG presentation
Hepatitis b virus for PG presentationHepatitis b virus for PG presentation
Hepatitis b virus for PG presentationSreejith SL
 
01 hans nauwynck
01 hans nauwynck01 hans nauwynck
01 hans nauwynckMerial EMEA
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomolLala Duque
 

What's hot (18)

THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...
THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...
THERAPEUTIC POTENTIALS OF POMEGRANATE IN SARS COV-2 AND ACUTE RESPIRATORY DIS...
 
Means of Treating Botulinum Neurotoxin Persistence
Means of Treating Botulinum Neurotoxin PersistenceMeans of Treating Botulinum Neurotoxin Persistence
Means of Treating Botulinum Neurotoxin Persistence
 
applications of polymerase chain reaction
applications of polymerase chain reactionapplications of polymerase chain reaction
applications of polymerase chain reaction
 
Mdadar 3
Mdadar   3Mdadar   3
Mdadar 3
 
Viruses fight back against rn ai technology
Viruses fight back against rn ai technologyViruses fight back against rn ai technology
Viruses fight back against rn ai technology
 
Izortze diatrain
Izortze diatrainIzortze diatrain
Izortze diatrain
 
HIV Vaccines
HIV VaccinesHIV Vaccines
HIV Vaccines
 
Gann 112.006
Gann 112.006Gann 112.006
Gann 112.006
 
SynTura Technology
SynTura TechnologySynTura Technology
SynTura Technology
 
Humanretroviruses 120401050128-phpapp01
Humanretroviruses 120401050128-phpapp01Humanretroviruses 120401050128-phpapp01
Humanretroviruses 120401050128-phpapp01
 
Gene therapy 2010
Gene therapy 2010Gene therapy 2010
Gene therapy 2010
 
12 merialberlinhansnauwynck
12 merialberlinhansnauwynck12 merialberlinhansnauwynck
12 merialberlinhansnauwynck
 
PhD; Qualification exam (mesele)2
PhD; Qualification exam (mesele)2PhD; Qualification exam (mesele)2
PhD; Qualification exam (mesele)2
 
Hepatitis b virus for PG presentation
Hepatitis b virus for PG presentationHepatitis b virus for PG presentation
Hepatitis b virus for PG presentation
 
01 hans nauwynck
01 hans nauwynck01 hans nauwynck
01 hans nauwynck
 
Dodds
DoddsDodds
Dodds
 
Emerging MOAs in lupus
Emerging MOAs in lupusEmerging MOAs in lupus
Emerging MOAs in lupus
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomol
 

More from Kimberly Schafer

Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01
Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01
Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01Kimberly Schafer
 
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01Kimberly Schafer
 
Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06Kimberly Schafer
 
Virologic monitoring during ART
Virologic monitoring during ARTVirologic monitoring during ART
Virologic monitoring during ARTKimberly Schafer
 
Test for HIV-associated cognitive impairment in India
Test for HIV-associated cognitive impairment in IndiaTest for HIV-associated cognitive impairment in India
Test for HIV-associated cognitive impairment in IndiaKimberly Schafer
 
TB and HIV screening in healthcare workers in a Mozambique hospital
TB and HIV screening in healthcare workers in a Mozambique hospitalTB and HIV screening in healthcare workers in a Mozambique hospital
TB and HIV screening in healthcare workers in a Mozambique hospitalKimberly Schafer
 
Clinical Care Quality Improvement in a Mozambique Hospital
Clinical Care Quality Improvement in a Mozambique HospitalClinical Care Quality Improvement in a Mozambique Hospital
Clinical Care Quality Improvement in a Mozambique HospitalKimberly Schafer
 
Quality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoQuality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoKimberly Schafer
 
Mixed methods study of IDU FSW in Mexico
Mixed methods study of IDU FSW in MexicoMixed methods study of IDU FSW in Mexico
Mixed methods study of IDU FSW in MexicoKimberly Schafer
 
Video Directly Observed Therapy for HIV and TB patients
Video Directly Observed Therapy for HIV and TB patientsVideo Directly Observed Therapy for HIV and TB patients
Video Directly Observed Therapy for HIV and TB patientsKimberly Schafer
 

More from Kimberly Schafer (10)

Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01
Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01
Del-Rio- The-Past-Present-and-Future-of-Global-Health-2010-10-01
 
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01
Goosby-Global-Health-Delivery-and-Diplomacy-2014-10-01
 
Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06
 
Virologic monitoring during ART
Virologic monitoring during ARTVirologic monitoring during ART
Virologic monitoring during ART
 
Test for HIV-associated cognitive impairment in India
Test for HIV-associated cognitive impairment in IndiaTest for HIV-associated cognitive impairment in India
Test for HIV-associated cognitive impairment in India
 
TB and HIV screening in healthcare workers in a Mozambique hospital
TB and HIV screening in healthcare workers in a Mozambique hospitalTB and HIV screening in healthcare workers in a Mozambique hospital
TB and HIV screening in healthcare workers in a Mozambique hospital
 
Clinical Care Quality Improvement in a Mozambique Hospital
Clinical Care Quality Improvement in a Mozambique HospitalClinical Care Quality Improvement in a Mozambique Hospital
Clinical Care Quality Improvement in a Mozambique Hospital
 
Quality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoQuality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in Mexico
 
Mixed methods study of IDU FSW in Mexico
Mixed methods study of IDU FSW in MexicoMixed methods study of IDU FSW in Mexico
Mixed methods study of IDU FSW in Mexico
 
Video Directly Observed Therapy for HIV and TB patients
Video Directly Observed Therapy for HIV and TB patientsVideo Directly Observed Therapy for HIV and TB patients
Video Directly Observed Therapy for HIV and TB patients
 

Skowronski samhd1-20121105

  • 1. Innate immunity and HIV infection Jacek Skowronski, PhD Case Western Reserve University November 5, 2012
  • 2. vif vpu HIV-1 gag pol env vpr nef vif gag HIV-2/SIVsm pol env vpx, vpr nef 1. Background: HIV accessory virulence factors Vpx and Vpr 2. Vpx and Vpr function through CRL4DCAF1 E3 ubiquitin ligase 3. Identification of cellular protein, SAMHD1, Vpx targets for degradation via CRL4DCAF1 4. SAMHD1 inhibits HIV infection in quiescent cells 5. Ongoing SAMHD1 studies
  • 3. The innate immune system protects from viral infection. Short J A Bioscience Horizons 2009;2:212-224
  • 4. The innate immune system matrix. Block IFN synthesis IFN – R decoys Block IFN signaling Block ISG function Short J A Bioscience Horizons 2009;2:212-224
  • 5. The innate immune system matrix. TRIM5 TRIM28/KAP1 APOBEC3G/F Tetherin/BST2 Schlafen 11 XYZ?? Short J A Bioscience Horizons 2009;2:212-224
  • 6. The innate immune system matrix. TRIM5 HIV: TRIM28/KAP1 Evades APOBEC3G/F Counteracts Tetherin/BST2 Ignores Schlafen 11 X ?? Short J A Bioscience Horizons 2009;2:212-224
  • 7. HIV accessory proteins program degradation of restriction factors vif vpu HIV-1 gag pol env vpr nef vif gag HIV-2/SIVsm pol env vpx, vpr nef Target: Accessory protein E3 Ubiqitin ligase: APOBEC3G/F Vif CRL5 Tetherin Vpu SCF--TrCP XYZ?? Vpr, Vpx CRL4-DCAF1 –> degradation by proteasome
  • 8. HIV accessory proteins program degradation of restriction factors Function and regulation of E3 Ubiquitin ligases Roc1 target Nedd8 (CyP F) Ub E2 E1 26 S proteasome Ub E3 E3 E2 E1 Ub UbUbUbUbUb Nedd8 CSN target target
  • 9. HIV accessory proteins program degradation of restriction factors HIV-1 gag pol env vpr gag HIV-2/SIVsm pol env vpx, vpr Target: Accessory protein E3 Ubiqitin ligase: APOBEC3G/F Vif CRL5 Tetherin Vpu SCF--TrCP XYZ?? Vpr, Vpx CRL4-DCAF1 –> degradation by proteasome
  • 10. Vpr and Vpx functions: DNA damage Transduction Transcription checkpoint (G2) of Macrophages/DC Vpr (HIV-1) +++ ++ + Vpr (SIVmac) +++ ? – Vpx (SIVmac) – ? +++++ HIV-1 Vpr MEQAP-EDQGPQ--REPYNEWTLELLEELKSEAVRHFPRIWLHNLGRHIYETYGDTWAGVEAIIR-----ILQQLPFIHFRIGCRHSRIGV-TRQRRARNG--ASRS* SIVmac Vpr MEERPPENEGPQ--REPWDEWVVEVLEELKEEALKHFDPRLLTALGNHIYNRHGDTLEGAGELIR-----ILQRALFMHFRGGCIHSRIGQ-PGGGNPLSAIPPSRSML* SIVmac Vpx MSDPRERIPPGNSGEETIGEAF-EWLNRTVEEINREAVNHLPRELIFQVWQRSWEYWHDEQGMSPSYVKYRYLCLIQKALFMHCKKGCRCLGEGHGAGGWRPGPPPPPPPGLA*    X-RAY NMR   
  • 11. Vpx overcomes inhibition of HIV infection of MDM and MDDC Negre et al. (2000) Gene Ther 7:1613 Goujon et al. (2007) Retrovirology 4:2 Kaushik et al. (2009) Cell Host Microbe 6:68 Pertel et al. (2011) Retrovirology 8:49
  • 12. Vpx and Vpr target CRL4 DCAF1 E3 Ubiquitin ligase CRL4 E3 Vpx/Vpr architecture Complex Identification DDB1 Catalytic core Cullin 4 specificity Substrate CSN DCAF1 Vpx, Vpr Epitope tagging Expression Vpx/Vpr-bound protein complex Affinity purification DDA1 DDB1 DCAF1 specificity Substrate LC-MS/MS Vpr/ (shotgun/MudPIT) Vpx
  • 13. Architecture of Cullin 4-based E3 ubiquitin ligase complexes “WD40” substrate receptors: Catalytic core DDB1 DCAF1-19 Cullin 4 specificity Substrate DDB2 CSN CSA “WD40” Cdt2 VprBP/DCAF1 10% sucrose 40% Vpr/Vpx bound complex: Blot: 66 232 660 kD DDA1 DCAF1 DDB1 IP: DDB1 DCAF1 VprBP specificity Substrate DDA1 VprBP Vpr/ DCAF1 Vpx IP: DDB1 Vpr DDA1 Vpr
  • 14. Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3 E3 active or inactive ? DDB1 Vpr/Vpx DCAF1 DDB1 DDB1 Cullin 4 Cullin 4 DCAF1 DCAF1 Cullin 4
  • 15. Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3 Roc1 target Assembly of Cul4DCAF1 E3 Nedd8 (CyP F) + / - Vpr in HEK 293T cells E2 Ub E3 E3 Purification via DCAF1 subunit E2 CSN Incubation with E2 & Ubiquitin Nedd8 Ub target SDS PAGE for poly-Ub Cul4 26 S DDB1 DDB1 proteasome Cullin 4 Cullin 4 Ub DCAF1 DCAF1 Ub Ub Vpr Ub tag tag target “WD40”: DCAF1
  • 16. Vpr (&Vpx) stimulates catalysis by Cul4DCAF1 E3 Vpr: – – + – + target E2: – – – + + Nedd8 E2 Ub E3 E3 Cul4(Ub)n E2 Cul4 Nedd8 Ub target 1 2 3 4 5 26 S DDB1 DDB1 Cullin 4 proteasome Cullin 4 Ub DCAF1 DCAF1 Ub Ub Vpr Ub tag tag target “WD40”: DCAF1
  • 17. Vpr (&Vpx) elevates neddylation of DCAF1 associated Cul4 IP: f-Vpr f-DCAF1 f-DDB2 Nedd8 f–Vpr: + + + – – – – – – – – – – f–VprBP: – – – – + + + – – – – – – f–DDB2: – – – – – – – – + + + + – m-Cul4A: – + + + – + + + – + + + + Vpr: + + + + – – + + – + – + + E3 E3 VprBP: – – + + + + + – – – + + + Extract Cul4 * Nedd8 Cul4 * IP Nedd8 * DDB1 DDB1 DDB1 Cullin 4 Cullin 4 Cullin 4 DCAF1 VprBP DCAF1 VprBP DDB2 tag Vpr tag tag “WD40”: VprBP DCAF1 “WD40”: DDB2
  • 18. Vpx/Vpr usurp CRL4DCAF1 to destroy novel restriction factors Roc1 Nedd8 (CyP F) Vpr E3 Vpx E3 Nedd8 CSN
  • 19. Vpx/Vpr usurp CRL4DCAF1 to destroy novel restriction factors Novel Restriction Factors for HIV/SIV Roc1 Nedd8 (CyP F) Ub E1 26 S Vpx E2 proteasome Ub E3 Vpr E3 E2 E1 Ub UbUbUbUbUb Nedd8 CSN Le Rouzic et al. 2007 Cell Cycle 6:182-8 Schröfelbauer et al. 2007. PNAS 104::4130-5 Hrecka et al. 2007. PNAS 104:11778-83 De Hart et al. 2007 Virol J. 4:57 Wen et al. 2007 JBC 282:27046-57 Srivastava et al. 2009 PLoS Path. 4:e1000059 …
  • 20. Searches for substrates recruited by Vpr/Vpx to CRL4DCAF1 E3 1. Substrate trapping by Vpx/Vpr on CRL4DCAF1 1. Global analysis of DC proteomes following SIV VLP(Vpx) infection
  • 21. Substrate trapping on CRL4DCAF1 by Vpx/Vpr Vpx CRL4DCAF1–Vpx CRL4DCAF1 CRL4DCAF1–Vpr Vpr (H/S) DDA1 DDA1 DDA1 DDB1 DDB1 DDB1 Cullin 4 Cullin 4 Cullin 4 HA- HA- HA- FLAG- HA- FLAG- FLAG- FLAG- FLAG- HA- transient co-expression affinity purification of E3 complexes MudPIT
  • 22. Cellular proteins loaded by Vpx onto CRL4DCAF1 by Vpx
  • 23. Putative Vpx substrates trapped on CRL4DCAF1
  • 24. MudPIT analysis of MDDC proteomes following SIV VLP(Vpx) infection CD14+ monocytes GMCSF, IL-4 MDDC (+/- type I IFN) SIV VLP +/- Vpx Extracts (cyt or nuc) MudPIT
  • 25. Analysis of MDDC proteomes identifies SAMHD1 as Vpx target MDDC SIV VLP IFN SAMHD1 A3C A3A  spectra  proteins extract Cytoplasmic – – 35 0 0 14085 1048 Nuclear – – 17 10 0 18077 1992 Cytoplasmic Vpx – 0 2 0 25878 1536 Nuclear Vpx – 0 5 0 15803 1714 Cytoplasmic – IFN 65 1 7 28047 1912 Nuclear – IFN 39 6 2 16962 2018 Cytoplasmic Vpx IFN 0 0 13 33280 2158 Nuclear Vpx IFN 0 10 2 25619 2498
  • 26. Analysis of MDDC proteomes also identifies SAMHD1 as Vpx target MDDC SIV VLP IFN SAMHD1 A3C A3A  spectra  proteins extract Cytoplasmic – – 35 0 0 14085 1048 Nuclear – – 17 10 0 18077 1992 Cytoplasmic Vpx – 0 2 0 25878 1536 Nuclear Vpx – 0 5 0 15803 1714 Cytoplasmic – IFN 65 1 7 28047 1912 Nuclear – IFN 39 6 2 16962 2018 Cytoplasmic Vpx IFN 0 0 13 33280 2158 Nuclear Vpx IFN 0 10 2 25619 2498
  • 27. SAMHD1 inhibits HIV infection and is targeted by Vpx for degradation via CRL4DCAF1
  • 28. Vpx-recruits SAMHD1 to CRL4DCAF1 complex
  • 29. Vpx programs SAMHD1 degradation via CRL4DCAF1 in MDM
  • 30. SAMHD1 inhibits HIV/SIV infection in macrophages MDM D0 Monocytes +GMCSF D3 VLPVpx D6 siRNA D9 infect/western D10 Q-PCR D12 FACS
  • 31. SAMHD1 inhibits HIV/SIV infection in macrophages Protocol D0 Monocytes +GMCSF D3 VLPVpx D6 siRNA D9 infect/western D10 Q-PCR D12 FACS
  • 32. SAMHD1 inhibits HIV/SIV infection in macrophages
  • 33. Conclusions 1. SAMHD1 inhibits HIV/SIV infection in macrophages, and other monocyte derived cell lineages. 2. SAMHD1 inhibits infection by interfering with viral cDNA synthesis. 3. SAMHD1 restriction is counteracted by Vpx. 4. Vpx targets SAMHD1 for proteasomal degradation via CRL4DCAF1 E3 Ub ligase. Hrecka et al. 2011 Nature 474:658-61 Laguette et al. 2011 Nature 474:654-7 Berger et al. 2011 PLoS Pathogens 7:e1002425
  • 34. SAMHD1: short story SAMHD1 SAMHD1 (626aa) 1. dGTP-dependent dNTPase HD 2. Located in nucleus SAM 3. Expressed in most leukocytes (HSC, B, allo COG1078 T, monocytes) site Anti-inflamatory 5. Loss of function (lof) SAMHD1 mutations dNTP dN + PPP are associated with autoimmune inflammatory condition (AGS) resembling congenital viral infection. 6. AGS is also caused by lof mutations in ? nucleases TREX1 and RNAseH2. RT 7. SAMHD1, TREX1 and RNAseH2 prevent accumulation of cellular immuno- stimulatory DNA that activates type I IFN endo-immuno- stimulatory DNA Viral cDNA response via cytoplasmic sensors. Anti-viral IFN 7. Inhibits HIV/SIV cDNA synthesis by suppressing dNTP pools below the threshold required for RT to function anti-inflamatory anti-HIV efficiently. (AGS)
  • 35. Outstanding questions: Anti-viral: • SAMHD1 functions important for anti–viral function, besides catalytic activity. • is SAMHD1 proximity to RTC important • RTC recognition • is restriction regulated • how does Vpx counteract SAMHD1 • SAMHD1 and innate response to HIV • does SAMHD1 prevent HIV triggering of innate sensors and type I IFN response in monocytes/DC/macrophages? • Identity of cytoplasmic sensors that mediate this response Anti-inflamatory • what is the nature of immunostimulatory DNA whose accumulation SAMHD1 prevents? • cytoplasmic sensors that mediate type I interferon response
  • 36. Collaborators: Case: Case: David McDonald Caili Hao Marcin Golczak Michael Lederman Kasia Hrecka Sarabpreet Kaur Stowers Institute: Sheeba Rasheedi Mike Washburn Chuanping Wang Laurence Florens Junpeng Yan Selene K . Swanson U. Pitt & PCHPI: CSHL Angela Gronenborn Joanne Yeh Jinwoo Ahn Magda Gierszewska* Smita Srivastava* Skirball Inst. & HHMI: Dan Littman Nicolas Manel